107. Juvenile idiopathic arthritis Clinical trials / Disease details


Clinical trials : 441 Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-003956-18-NL
(EUCTR)
29/04/201413/01/2014Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis (JIA)Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis (JIA) - PREVENT-JIA juvenile idiopathic arthritis
MedDRA version: 16.1;Level: LLT;Classification code 10059177;Term: Juvenile arthritis;System Organ Class: 100000004859;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Trade Name: enbrel
Product Name: enbrel
Product Code: EU/1/99/126/001
INN or Proposed INN: ETANERCEPT
Other descriptive name: enbrel
Trade Name: humira
Product Name: humira
Product Code: EU/1/03/256/001
INN or Proposed INN: ADALIMUMAB
Other descriptive name: humira
Trade Name: orencia
Product Name: orencia
Product Code: EU/1/07/389/001
INN or Proposed INN: ABATACEPT
Other descriptive name: orencia
Trade Name: methotrexate
Product Name: methotrexate
Product Code: RVG 28636
INN or Proposed INN: methotrexate
Other descriptive name: METHOTREXATE
Trade Name: methotrexate
Product Name: Methotrexate
Product Code: RVG 104433
INN or Proposed INN: methotrexate
Other descriptive name: METHOTREXATE
University Medical Center UtrechtNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
325United States;Canada;Latvia;Germany;Netherlands